.Pharmacolibrary.Drugs.ATC.N.N05CD09 .Pharmacolibrary.Drugs.ATC.N.N05CD09| name: | Brotizolam | |
| ATC code: | N05CD09 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 0.25 | mg |
| volume of distribution: | 0.61 | L |
| clearance: | 1.36 | L/h |
| other parameters in model implementation | ||
Brotizolam is a short-acting thienotriazolodiazepine, a benzodiazepine derivative, mainly used as a hypnotic for the short-term treatment of severe insomnia. It has potent sedative and anxiolytic properties. Brotizolam is approved for clinical use in a number of countries, including Japan and some European countries, but is not approved in the United States or Canada.
Pharmacokinetic parameters reported in healthy adult volunteers (both sexes), typically fasted, who received oral administration.